Amicus Brief: Areli Escobar 2024

Areli Escobar v. The State of Texas


Filing Date
March 28, 2024

Charge
Capital Murder

Jurisdiction
Supreme Court of the United States

Partners
Innocence Network


 

Summary

CIFS and the Innocence Network filed this amicus brief in the Supreme Court of the United States in Areli Escobar’s case. This brief follows our 2022 amicus brief which sent the case back to the Texas Court of Criminal Appeals (TCCA) for further review. The TCCA came to the same conclusion, denying relief. This 2024 amicus brief in Escobar’s case asks SCOTUS to intervene because the TCCA will not.

PRELIMINARY STATEMENT 

When used properly, this evidence has the potential to decisively advance the truth-seeking function of trials. But the power of DNA evidence carries significant risks when such evidence is used improperly. There is growing recognition that jurors are at risk of viewing DNA testing as infallible, with little regard to how it has been prepared or presented. “Given the persuasiveness of such evidence in the eyes of the jury,” this Court has emphasized, “it is important that [DNA

evidence] be presented in a fair and reliable manner” to avoid wrongful convictions. McDaniel v. Brown, 558 U.S. 120, 136 (2010). This case shows why. Petitioner Areli Escobar was convicted and ultimately sentenced to death based on DNA testing that was later shown by the defendant, and conceded by the prosecution, to be unreliable. Indeed, the purported DNA evidence was so flawed that the municipal forensics lab that collected, analyzed, and provided the crucial testimony on the DNA was shuttered for violations of professional standards so egregious and intractable that the lab could not be reopened.

The lab’s misconduct was on full display in Mr. Escobar’s case. The DNA evidence was exposed to severe contamination risks at the lab and the analysts assigned to this case repeatedly ignored best practices and engaged in bias-driven manipulation of the testing to incriminate Mr. Escobar. The prosecution used this false testing as the centerpiece of its case, and one juror stated publicly that the DNA evidence took him off the fence and convinced him to join a guilty verdict. As even Mr. Escobar’s prosecutors now recognize, no one should be sentenced to death based on a trial that rested on such fundamentally flawed evidence.

Previous
Previous

Amicus Brief: Lawrence Keith Johnson

Next
Next

Amicus Brief: Julian Gallardo